The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambria Africa Regulatory News (CMB)

  • This share is currently suspended. It was suspended at a price of 0.225

Share Price Information for Cambria Africa (CMB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.225
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.225
CMB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update FY 2021

28 Feb 2022 16:20

RNS Number : 0798D
Cambria Africa PLC
28 February 2022
 

Cambria Africa Plc

("Cambria" or the "Company")

 

Trading Update FY 2021

Unaudited EPS of 0.03 US cents and NAV of 1.16 US cents

 

Cambria Africa PLC (AIM: CMB) ("Cambria" or the "Company") announces its unaudited FY 2021 accounts for the 12 months ended 31 August 2021. Audited results and annual report was delayed due to the impact of the Omicron Virus on our resources and will become available by end March 2021. A copy of this announcement is available on the Company's website (www.cambriaafrica.com).

 

Cambria earned 0.03 US cents per share during FY 2021 compared to a loss of 0.07 cents share in FY 2020. Despite the turnaround in earnings, NAV declined by US $79,000 from 1.18 US cents to 1.16 US cents per share. The decline despite the earnings contribution was due to a market valuation drop of $200,000 for the Company's business property from US $2.3 million to US $2.1 million (valuation by Hollands conducted on the 27th of January 2022). As at 28 February 2022, total cash on hand is $1.556(0.29 US cents) million including $1.330 million in Cambria's accounts outside Zimbabwe (85% of cash resources). Cash balances were down 6% from the Fiscal Year end 2021 mainly related fees for maintaining the listing. NAV is estimated to be at 1.15 cents per share as of 28 February 2022. The Company continues to rationalise its operations by reducing staff costs and overheads - and maximizing the value to shareholders from the remaining hard assets, intellectual property, and cash.

 

Tradanet, a 51% owned subsidiary of Paynet Zimbabwe, which processes microloans for CABS (Zimbabwe's largest building society), is the Company's most profitable operation. The turnaround is attributable to loan values and salaries catching up with inflation.

 

Autopay - the Company's Payroll operation saw its revenues decline as Paywell granted non-exclusive licenses to multiple competitors including former employees. During the Fiscal Year 2021, the company reached a management agreement with Propay (Pvt) Ltd and established former account executives as independent contractors. This has resulted in significant cost containment and aligning the incentives of Payroll executives with that of Autopay.

 

Millchem's remaining business, the production of sanitisers and disinfectants, traded marginally positive. The sector has been characterised by significant competition and ease of entry by multiple small players in the chemicals industry. With the lower disposable income of the general population, high quality sanitizers have lost market share. Our joint venture with Merken (Pvt) Ltd. remains cash flow positive, but will likely wind down by the end of this Fiscal Year if demand does not improve.

 

Officially, the value of the Zimbabwe dollar (ZWL) to the US dollar fell by 2% since the prior trading year however these figures belie the true depreciation in the market value and purchasing power of the Zimbabwe dollar from FY ended 31 August 2020 to 31 August 2022. The fall in the purchasing power of the local currency has continued in the six months since the end of the Company's fiscal year. As elections near, uncertainty increases, while economic policies remain fluid and unpredictable.

 

The strategic goals of the Company in FY 2021 have been, and continue to be, as follows:

 

- Conserving of cash resources of US$1.65 million

- Achieving value for US $1.35 million held by the Reserve Bank of Zimbabwe (RBZ) as "Legacy Debts" or "Blocked Funds". This asset has been deprecated in our accounts to the official value until such time as the RBZ honours this commitment.

- Achieving value for US $175,000 of Old Mutual shares at the current JSE market value through repatriation of these shares to the Johannesburg register where they were transferred from to the Zimbabwe Stock Exchange (ZSE). This transfer was in reliance on fungibility of dual listed shares. Fungibility of multi-listed shares has been withdrawn by action of the Zimbabwe government and acquiescence of Old Mutual plc. The shares continue to be suspended on the ZSE

- Achieving and maximizing full international value for the equivalent holding of $4.98 million in equivalent shares of Radar Holdings plc at 35 US cents per share or US $1.743 million.

- Maximizing value for the Company's intellectual property both in current and future operations.

 

We remain cautiously optimistic about achieving full value for the Company's assets even beyond its NAV. At this point in time, we feel it is still possible to increase shareholder wealth through appreciation of the Company's share price to reflect at the very least, its net equity, which is for all intents and purposes is debt free. This should bring the market valuation as of 28 February 2022 of 0.3752 US cents per share closer to the Company's current NAV of 1.15 US cents per share a three-fold difference.

 

Cambria remains poised to take advantage of a turnaround in the economy through the stabilization of market-driven policies, which may yet take hold in Zimbabwe. Until such time, we will pursue the above mentioned strategies to maintain and improve shareholder value.

 

Extension of Reporting Deadline

 

Due to the effect of COVID-19 pandemic, the Company will not be able to post its annual audited report and accounts for the financial year ended 31 August 2021 (the "Annual Report") to shareholders by 28 February 2022. The Company has applied, pursuant to the guidance provided in "Inside AIM" on 27 January 2021, for an additional period to publish the Annual Report. The Company has been granted the extension and therefore the Company will publish the Annual Report by no later than 31 March 2022.

 

 

Contacts

 

 

 

Cambria Africa Plc

www.cambriaafrica.com

Samir Shasha

+44 (0)20 3287 8814

 

 

WH Ireland Limited

https://www.whirelandplc.com/

James Joyce / Ben Good

+44 (0) 20 7220 1666

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTPMFTMTBTBPT
Date   Source Headline
1st Mar 20247:30 amRNSSuspension - Cambria Africa PLC
16th Feb 20247:00 amRNSHolding(s) in Company
9th Feb 202410:14 amRNSFinal Results Status and Update
4th Jan 20246:03 pmRNSHolding(s) in Company
15th Sep 20237:30 amRNSRestoration - Cambria Africa plc
14th Sep 20235:00 pmRNSInterim Results
14th Sep 20235:00 pmRNSAudited FY 2022 Results
11th Jul 20233:29 pmRNSProposed Paynet Software Agreement
31st May 20237:57 amRNSFinal and Interim Results status
1st Mar 20237:30 amRNSSuspension - Cambria Africa PLC
20th Feb 20232:39 pmRNSFinal Results Status and Update
27th Oct 202212:16 pmRNSInvestment update
30th May 20224:28 pmRNSInterim Results
31st Mar 20224:25 pmRNSAudited FY 2021 Results
28th Feb 20226:33 pmRNSREPLACEMENT - Trading Update FY 2021
28th Feb 20224:20 pmRNSTrading Update FY 2021
30th Jun 20213:00 pmRNSInterim Results
17th Jun 20217:30 amRNSRestoration - Cambria Africa plc
16th Jun 20214:30 pmRNSAudited FY 2020 Results
1st Jun 20217:30 amRNSSuspension - Cambria Africa PLC
28th May 20213:02 pmRNSNotice of Final Results and Interim Results
26th Feb 202111:21 amRNSTrading Update and Extension of Reporting Deadline
21st Sep 20204:34 pmRNSTrading and operational update
29th May 20204:20 pmRNSInterim Results
30th Mar 202011:00 amRNSPrice Monitoring Extension
28th Feb 202011:50 amRNSAudited FY 2019 Results
18th Nov 20198:22 amRNSTrading and Legal Actions Update
6th Aug 20194:29 pmRNSPaynet and Adviser Update
4th Jul 20197:00 amRNSPaynet and Payserv Sue BAZ for US $100 million
12th Jun 20191:12 pmRNSSuspension of Banks on Paynet Zimbabwe Platform
12th Jun 201910:53 amRNSPaynet update - suspension of services to banks
31st May 20197:00 amRNSInterim Results
5th Apr 20197:00 amRNSNew Appointments at Payserv Zimbabwe
1st Feb 20197:45 amRNSAudited 2018 Results
15th Jan 201912:45 pmRNSAnnual Results Update
4th Dec 20188:18 amRNSAppointment of Joint Broker
15th Nov 20182:05 pmRNSSecond Price Monitoring Extn
15th Nov 20182:00 pmRNSPrice Monitoring Extension
8th Nov 201812:17 pmRNSPreliminary Unaudited Results
11th Oct 20189:00 amRNSCorporate Update
18th Sep 20181:58 pmRNSTrading Update and Radar Holdings Ltd Acquisiton
10th Jul 20182:45 pmRNSOpen Offer raises £2.1 million Equity
2nd Jul 20189:06 amRNSTrading Update & Open Offer Reminder
5th Jun 20187:00 amRNSPosting of Open Offer Circular
15th May 20181:38 pmRNSOpen Offer & Issue of Shares to Directors
20th Apr 20185:52 pmRNSInterim Results
27th Feb 20187:00 amRNSFY 2017 Audited Financial Results
21st Dec 20177:00 amRNSSubsidiary Appoints Sibert Dube CEO
23rd Oct 201710:33 amRNSTrading Statement
4th Oct 20173:15 pmRNSCompany Settles Dispute with Consilium

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.